Sino Biological Supports Tencent AI Lab Protein Design Study Published in Nature Communications
Sino Biological announced that its gene synthesis and cell free protein expression workflow was used by Tencent AI for Life Sciences Lab in a study published in Nature Communications, according to a press release. The collaboration enabled rapid validation of AI designed proteins with improved activity, stability, and multifunctionality.
The study introduced an Ontology Reinforcement Iteration framework that combines protein ontology with reinforcement learning based on experimental feedback. Data from protein expression levels and functional activity were fed back into the model to refine sequence design accuracy.
Tencent researchers used Sino Biological's XPressMAX Cell Free Protein Synthesis Kit to accelerate protein expression and functional screening. The workflow supported fast design, build, and test cycles, resulting in a lysozyme with more than 100 fold higher activity than the natural enzyme, a thermostable chitinase active at 85 degrees Celsius, and bifunctional enzymes with enhanced performance.
The XPressMAX kit allows protein expression in as little as three hours, supports various DNA templates, and is suitable for high throughput and industrial applications.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Sep 29 University Medical Center Göttingen Adopts MDClone Clinical Data Platform Sep 29 LUNGevity Awards $2 Million for Lung Nodule Risk Studies Sep 28 Deep Longevity to Launch Accrua Telehealth Platform in US Sep 28 United Imaging Intelligence Releases Medical Video AI Framework Sep 28 Orca Dental AI Brings CephX Imaging Tools to Planet DDS Cloud 9Life AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Industry analysis
2025 Global Business Services Agenda: Gen AI Takes Center Stage
This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.
Read moreYou may also like
ACROBiosystems Launches ACRO AIx and Rapid Antibody Validation Service
Sunthetics Joins $19.5M NSF Autonomous Lab Initiative
Basecamp Research Raises $140 Million for AI Designed Therapeutics
Insilico Medicine Opens AI Longevity Research Toolkit
Lunai Bioworks Tests AI Chemical Risk Screening Model
Daily AI Brief: the AI news that matters, in your inbox.